ASSAY FOR SARS-COV-2 INFECTION OF VULNERABLE HUMAN CELLS
Provided herein are methods and compositions useful for identifying compounds that can inhibit SARS-CoV-2 infection or the effects thereof, especially in cardiomyocytes (CMs), which are highly infectible by SARS-CoV-2 corona viruses.